secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xenetic Biosciences, Inc. (XBIO)
CIK:        0001534525
Form:       8-K
Filed at:   2022-12-22T23:59:59+00:00
Accession:  0001683168-22-008623
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Xenetic stockholders approve increase in authorized common stock from 50M to 100M shares
--------------------------------------------------------------------------------

- Proposal Four passed: 7,204,486 For, 1,131,034 Against, 110,245 Abstained, no broker non-votes.
- Amendment to Articles of Incorporation increases authorized common stock from 50M to 100M shares.
- Annual meeting reconvened on Dec. 21, 2022 solely for this proposal after initial adjournment on Dec. 7, 2022.
- No other matters were considered or voted upon at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534525/000168316822008623/0001683168-22-008623-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534525/000168316822008623/xenetic_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-22-008623

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer